Metabolais fragments

HGH Fragment 176-191 kalkulators

Aprēķiniet precīzus rekonstituēšanas tilpumus, insulīna vienības un devas no flakona jebkuram peptīdam.

Flakons, ūdens un deva ir zināmi

HGH Fragment 176-191Šis kalkulators ir iestatīts uz HGH Fragment 176-191

Peptīda daudzums (mg)

BAC ūdens (ml)

Deva (mcg)

parasti 100-500 mcg

mcgmg

Šļirces izmērs

Kalibrēšana

U-100U-40

Vienības ir tilpums, nevis aktīvā viela

Vienības mēra tilpumu, nevis aktīvo vielu. 5 SV = 0,05 ml. Cik mg tajā ir, atkarīgs no maisījuma. Kalkulators to jau ir aprēķinājis.

Gandrīz visas insulīna šļirces ir U-100. Izvēlieties U-40 tikai tad, ja šļirce ir marķēta ar U-40.

Jūsu rezultāts · tiešraidē

IUmlVienības

Uzvilkt

5IU

5 IU / 100 IU (0.050 ml)

Koncentrācija

5.00

mg/ml

Tilpums uz devu

0.050

Devas no flakona

devas

par devu

—

HGH Fragment 176-191

Galvenie fakti

Biežums: 1–2x daily
Tipiskais diapazons: 100-500 mcg

Zinātniskais profils

HGH Fragment 176-191 peptīdu leksikonā: mehānisms, pierādījumi un avoti

→

What Is HGH Fragment 176-191?

HGH Fragment 176-191 is a synthetic peptide composed of 16 amino acids that reproduces the C-terminal region of human growth hormone (somatropin). The intact growth hormone molecule contains 191 amino acids, and research conducted in the 1990s identified that the hormone's fat-burning properties are concentrated in a well-defined stretch spanning amino acids 176 through 191. This specific segment was isolated, synthetically reproduced, and stabilized for research purposes. The "176-191" designation therefore points directly to the position of this sequence within the full hormone molecule.

The central idea behind this fragment is functional separation. Whereas intact growth hormone exerts a wide range of effects on the organism — including growth, tissue building, and a marked rise in IGF-1 — HGH Fragment 176-191 isolates only the lipolytic (fat-mobilizing) portion. In preclinical models, the fragment was shown to stimulate fat breakdown without triggering the growth-promoting and glucose-related effects characteristic of full growth hormone to the same degree. For this reason, HGH Fragment 176-191 is frequently described in research as the "lipolytic fragment" of growth hormone.

HGH Fragment 176-191 is closely related to AOD-9604, another derivative of the same C-terminal region. AOD-9604 is a modified variant in which an additional tyrosine residue improves stability, and both compounds are discussed within the same metabolic research context. Importantly, the fragment is not a secretagogue: it does not stimulate the body's own release of growth hormone but acts directly on fat cells. This sets it apart fundamentally from GHRH analogs and ghrelin mimetics, which work through the pituitary. All information presented here relates strictly to the research context.

Mechanisms of Action

HGH Fragment 176-191 exerts its effects primarily by influencing fat metabolism in adipocytes (fat cells). The mechanisms investigated in research can be summarized as follows:

Stimulation of lipolysis: The fragment promotes the breakdown of triglycerides stored in fat cells into free fatty acids and glycerol. This process makes stored energy available for further metabolism and forms the core of the peptide's lipolytic activity.
Inhibition of lipogenesis: Alongside promoting fat breakdown, the fragment reduces the formation of new fat tissue in preclinical models by dampening the conversion of dietary components into new fat stores. The combined effect of increased breakdown and reduced buildup shifts the balance of fat metabolism.
Increased fat oxidation: Beyond simply releasing fatty acids, animal models suggest the fragment increases the actual burning of those fatty acids for energy. This is important, because released fatty acids could otherwise be re-stored in fat cells if not followed by oxidation.
No relevant rise in IGF-1: Unlike intact growth hormone, the fragment does not produce a pronounced increase in insulin-like growth factor 1 (IGF-1) in the research literature. As a result, the growth-promoting effects associated with IGF-1 are largely absent, which is considered a key distinction from the full hormone.
Limited effect on blood glucose: Full growth hormone can impair insulin sensitivity and raise blood sugar. HGH Fragment 176-191 showed a markedly smaller influence on glucose metabolism in preclinical studies, because the diabetogenic portion of the hormone lies outside the 176-191 sequence.
No action through the growth axis: The fragment does not bind the classical growth hormone receptor in a way that drives tissue growth, and it does not stimulate the pituitary. Its activity remains focused on fat metabolism, which explains its relatively narrow profile.

In summary, HGH Fragment 176-191 is intended to decouple the fat-mobilizing properties of growth hormone from its growth-related and metabolic side effects. Whether this theoretical profile holds up in robust human clinical data remains the subject of ongoing research.

Dosage Calculation

HGH Fragment 176-191 is dosed in micrograms (mcg) in the research context. Because the peptide has a short half-life, many protocols use a divided daily dose. Slow titration is generally not required, though starting at the lower end of the range is a reasonable precaution.

Standard Dosing Parameters

Conservative dose: 100 mcg (0.10 mg) per injection
Standard dose: 250 mcg (0.25 mg) per injection
Higher range: 400–500 mcg (0.40–0.50 mg) per injection
Frequency: Once or twice daily, with many protocols dosing in a fasted state in the morning and optionally before physical activity
Half-life: Approximately 2.5 hours, which explains the common practice of splitting the daily amount into several smaller doses
Typical syringe: 0.3 mL insulin syringe (29–31 gauge, 6–8 mm needle)

Example Calculation: 10 mg Vial with 2 mL BAC Water

A common vial size for HGH Fragment 176-191 is 10 mg. Adding 2 mL of bacteriostatic water gives a concentration of 5 mg/mL (5,000 mcg/mL).

100 mcg dose: 100 ÷ 5000 = 0.02 mL (2 units on a U100 syringe)
250 mcg dose: 250 ÷ 5000 = 0.05 mL (5 units)
400 mcg dose: 400 ÷ 5000 = 0.08 mL (8 units)
500 mcg dose: 500 ÷ 5000 = 0.10 mL (10 units)

At 250 mcg once daily, a 10 mg vial provides 40 days of dosing; at two 250 mcg doses per day, it lasts 20 days. Because small volumes are especially error-prone here, precise calculation is worthwhile. Use the HGH Fragment 176-191 calculator above to determine accurate volumes for any vial size, reconstitution volume, and target dose.

Injection Site and Timing Selection

HGH Fragment 176-191 is typically injected subcutaneously into the abdominal fat layer. Because the lipolytic effect is mediated systemically, targeting a specific fat depot with the injection is not necessary, and localized injection does not produce spot reduction of fat. Many research protocols time administration to a fasted state — for example, in the morning before the first meal — since a low insulin level favors lipolysis. Rotating injection sites reduces local irritation.

Reconstitution

HGH Fragment 176-191 is supplied as a lyophilized (freeze-dried) powder in sealed vials. It must be reconstituted with bacteriostatic water (BAC water) before use. BAC water contains 0.9% benzyl alcohol, which inhibits microbial growth and extends the usable window of the reconstituted solution. Sterile water for injection is less suitable for multi-dose vials because it contains no preservative.

Step-by-Step Reconstitution Protocol

Gather supplies: the HGH Fragment 176-191 vial, a vial of bacteriostatic water, alcohol swabs, a sterile draw needle (18–21 gauge), and your insulin syringe for injection.
Wipe the rubber septa of both vials with fresh alcohol swabs and allow them to air-dry for about 30 seconds. Do not touch or blow on the septa afterward.
Draw the desired volume of BAC water into the draw syringe. For a 10 mg vial, 2 mL is a common starting point that simplifies dose calculation.
Insert the needle into the peptide vial at an angle, directing the tip toward the inner glass wall rather than the powder cake. A direct stream of water onto the lyophilized powder can mechanically stress the delicate peptide bonds.
Slowly push the plunger so the BAC water runs down the inner glass wall and gently wets the powder from below.
Gently roll or swirl the vial between your palms until the powder is completely dissolved. The finished solution should appear clear and colorless. Do not shake or vortex the vial.
Label the vial with the reconstitution date and concentration, for example "HGH Fragment 176-191 5 mg/mL — reconstituted [date]".

If the solution appears cloudy, discolored, or contains visible particulate matter, the vial should be discarded and not used.

Storage and Shelf Life

Lyophilized powder (unreconstituted): Store at −20°C for long-term storage, where the powder remains stable for many months. Short-term storage at 2–8°C in a refrigerator is acceptable. Protect from light and moisture, and do not leave at room temperature for extended periods.
Reconstituted solution: Store in the refrigerator at 2–8°C and use within approximately 28–30 days. Keep the vial upright and away from light. Write the reconstitution date prominently on the label and discard the vial once the window has elapsed, regardless of remaining volume.
Do not freeze reconstituted peptide. Freeze-thaw cycles cause protein aggregation and a loss of biological activity. Once reconstituted, the vial must remain refrigerated throughout its use window.
Transport: Use an insulated cooler with an ice pack for any travel lasting more than one to two hours. Commercial insulated medication pouches maintain 2–8°C for 24–48 hours. Avoid exposure to temperatures above 25°C during transport.

Side Effects and Safety Profile

HGH Fragment 176-191 is described in preclinical research as generally well tolerated, particularly because of its narrower profile compared with full growth hormone. Since human clinical data is limited, all use remains in the research domain, and a definitive safety verdict is not possible.

Commonly Reported Observations

Mild redness, transient swelling, or brief discomfort at the injection site. These local reactions usually resolve within a few hours, and rotating injection sites reduces irritation.
Temporary fatigue or a sensation of hunger, which some users report with fasted use and which is associated with the mobilization of energy reserves.
An occasional flushing sensation or mild lightheadedness shortly after injection, which typically subsides quickly.

Less Common or Theoretical Concerns

Effect on blood glucose: Although the fragment is expected to influence glucose metabolism far less than full growth hormone, complete neutrality is not guaranteed. Individuals with impaired glucose metabolism should take this into account.
Allergic reactions: As with any injectable peptide, hypersensitivity reactions to the active compound or to the benzyl alcohol in BAC water are theoretically possible.
Limited long-term data: No extensive long-term human studies are available. The effects of sustained use over long periods are not adequately characterized.

Contraindications

Pregnancy and breastfeeding, due to a lack of robust safety data
Known hypersensitivity to the peptide or any component of the preparation
Active cancer without medical supervision

No serious adverse events specifically attributable to HGH Fragment 176-191 have been described in the available literature at standard research doses. Given the absence of large-scale human studies, caution is warranted, and consultation with a qualified healthcare professional is strongly recommended.

Combinations and Stacks

HGH Fragment 176-191 and AOD-9604

Because AOD-9604 is a closely related, stabilized variant of the same C-terminal region, the two compounds are generally regarded in research as alternatives rather than a stack to be used simultaneously. Those who want to examine the metabolic research question from two angles compare the profiles of the two fragments rather than combining them.

HGH Fragment 176-191 and GH Secretagogues

In practice, the fragment is frequently discussed in connection with peptides of the growth hormone axis. Secretagogues such as Ipamorelin or GHRH analogs such as CJC-1295 without DAC work through the body's own release of growth hormone, and therefore through a fundamentally different mechanism than the fragment, which acts directly on fat cells. The conceptual appeal of this combination lies in its complementarity: one element targets the hormone level, the other targets fat metabolism itself. Dosing details for these peptides are available in their respective calculators.

HGH Fragment 176-191 and Tesamorelin

Tesamorelin is a GHRH analog discussed in research specifically in connection with visceral fat tissue. Because Tesamorelin works through the growth hormone axis while the fragment acts directly through lipolysis, the two compounds address different levels of fat metabolism. The relevant parameters can be reviewed using the Tesamorelin calculator.

Frequently Asked Questions

How does HGH Fragment 176-191 differ from real growth hormone?

Real growth hormone is a complete 191-amino-acid protein with a broad range of effects, including growth, tissue building, and a marked rise in IGF-1. HGH Fragment 176-191, by contrast, reproduces only the C-terminal region in which the fat-mobilizing activity is located. The fragment is therefore intended to stimulate lipolysis without triggering the growth-promoting and glucose-related effects of the full hormone to the same extent.

Does the fragment raise IGF-1 levels?

According to the available preclinical literature, HGH Fragment 176-191 does not produce a pronounced increase in IGF-1. This property is considered a central distinguishing feature compared with intact growth hormone, since the hormone's growth-promoting effects are largely mediated through IGF-1.

Is the fragment a GH secretagogue?

No. A secretagogue stimulates the pituitary to release more of the body's own growth hormone. HGH Fragment 176-191 works differently: it acts directly on fat metabolism in the adipocytes and does not stimulate the pituitary. This sets it apart fundamentally from peptides such as Ipamorelin or GHRH analogs.

Why is the fragment often used in a fasted state?

A low insulin level favors lipolysis, while an elevated insulin level dampens fat mobilization. For this reason, many research protocols time administration to a fasted state — for example, in the morning before the first meal or before physical activity — so that the fat-mobilizing effect is not blunted by a concurrent meal.

Does injecting into a specific body area cause local fat loss?

No. The effect of HGH Fragment 176-191 is mediated systemically. Injecting into the abdomen or another region does not produce targeted breakdown of fat tissue at that site. The choice of injection site is therefore based on practical considerations rather than a desire for a localized effect.

How do HGH Fragment 176-191 and AOD-9604 differ?

Both compounds are derived from the same C-terminal region of growth hormone. AOD-9604 is a modified variant in which an additional tyrosine residue improves the stability of the sequence. HGH Fragment 176-191, by contrast, corresponds to the unmodified fragment sequence. In research, both are considered within the same metabolic context and are usually compared as alternatives.

Why is the fragment often dosed several times per day?

The half-life of HGH Fragment 176-191 is approximately 2.5 hours, so the peptide is cleared from the circulation relatively quickly. To achieve more even exposure across the day, many protocols split the daily amount into one or two smaller doses rather than administering it in a single dose.

Where can I buy HGH Fragment 176-191?

Medical Disclaimer: The information on this page is provided for educational and research purposes only. HGH Fragment 176-191 is not an approved drug or medical treatment and is sold strictly for research use. Nothing on this page constitutes medical advice, diagnosis, or a recommendation to use any specific compound. Always consult a qualified healthcare professional before beginning any peptide protocol. BergdorfBio assumes no liability for the use or misuse of the information presented here.

Soli pa solim

Kā rekonstituēt peptīdu

No pulvera līdz gatavai šļircei piecos soļos. Kalkulators augstāk automātiski aprēķina daudzumus.

011
Sagatavojiet BAC ūdeni
Ļaujiet flakonam un ūdenim sasilt līdz istabas temperatūrai. Noslaukiet abus gumijas aizbāžņus ar spirta salveti.
022
Uzvelciet ūdeni
Ar lielāku šļirci uzvelciet tādu BAC ūdens daudzumu, kādu iesaka kalkulators.
033
Pievienojiet lēni
Ļaujiet ūdenim notecēt pa peptīda flakona iekšējo sienu; neizsmidziniet to tieši uz pulvera.
044
Ļaujiet izšķīst
Maigi pagroziet flakonu, nekratiet. Pulveris 1-2 minūšu laikā izšķīst līdz dzidram šķīdumam.
055
Uzvelciet devu
Ar insulīna šļirci uzvelciet tieši līdz aprēķinātajai atzīmei. Gatavs.

Uzziņa

Devas un flakonu izmēri pa peptīdiem

Tipiskas sākuma vērtības orientācijai. Katra rinda atver kalkulatoru šim peptīdam.

Peptīds	Kategorija	Tipiskā deva	Flakonu izmēri	BAC (sākums)	Pieejamība	Aprēķināt
VIP	Neiropetīdu pētniecība	-	10 mg	2 ml	Tikai kalkulators	Aprēķināt
Retatrutide	GLP-1/GIP/GCG	0,5-12 mg	2 / 5 / 10 / 15 mg	2 ml	Tikai kalkulators	Aprēķināt
Cagrilintide	Amilīna analogs	-	5 mg	2 ml	Tikai kalkulators	Aprēķināt
Semaglutide	GLP-1	0,25-2,4 mg	2 / 5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Tirzepatide	GLP-1/GIP	2,5-15 mg	10 / 15 / 20 / 30 / 60 / 90 mg	2 ml	Tikai kalkulators	Aprēķināt
GHK-Cu	Vara peptīds	1-4 mg	10 / 20 / 50 mg	5 ml	Tikai kalkulators	Aprēķināt
AHK-Cu	Vara peptīds	-	100 mg	5 ml	Tikai kalkulators	Aprēķināt
BPC-157	Audu atjaunošana	0,2-0,5 mg	2 / 5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
TB-500	Thymosin Beta-4	2-5 mg	2 / 5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
CJC-1295 (bez DAC)	GHRH analogs	100-200 mcg	2 / 5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Ipamorelin	GHRP	200-300 mcg	2 / 5 mg	2 ml	Tikai kalkulators	Aprēķināt
AOD-9604	Tauku vielmaiņa	250-500 mcg	2 / 5 mg	2 ml	Tikai kalkulators	Aprēķināt
PT-141	Bremelanotide	-	2 / 5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
MOTS-c	Mitohondriāls	5-10 mg	5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Selank	Anksiolītisks	150-500 mcg	2 / 5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
SS-31	Elamipretide	0,1-1 mg	5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Glow Stack	Stack	0,5-2 mg	70 mg	3 ml	Tikai kalkulators	Aprēķināt
Klow Stack	Stack	0,5-2 mg	55 mg	3 ml	Tikai kalkulators	Aprēķināt
Melanotan II	Melanokortīns	100-1000 mcg	5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Melanotan I	Melanokortīns	-	5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Sermorelin	GHRH analogs	50-300 mcg	5 mg	2 ml	Tikai kalkulators	Aprēķināt
Tesamorelin	GHRH analogs	1-2 mg	10 / 20 mg	2 ml	Tikai kalkulators	Aprēķināt
Thymosin Alpha-1	Timusa peptīds	0,8-3,2 mg	1.6 / 5 / 10 mg	1 ml	Tikai kalkulators	Aprēķināt
Epithalon	Ilgmūžība	2-10 mg	10 / 20 / 50 mg	2 ml	Tikai kalkulators	Aprēķināt
KPV	Imūnā sistēma / barjera	100-1000 mcg	5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
HGH Fragment 176-191	Metabolais fragments	100-500 mcg	2 / 5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Semax	Kognitīvs	100-1000 mcg	10 / 30 mg	2 ml	Tikai kalkulators	Aprēķināt
N-Acetyl Semax	Kognitīvs	100-1000 mcg	5 / 10 mg	2 ml	Tikai kalkulators	Aprēķināt
Hexarelin	GHRP	50-200 mcg	2 / 5 mg	2 ml	Tikai kalkulators	Aprēķināt
GHRP-6	GHRP	50-300 mcg	2 / 5 mg	2 ml	Tikai kalkulators	Aprēķināt
GHRP-2	GHRP	50-250 mcg	2 / 5 mg	2 ml	Tikai kalkulators	Aprēķināt
DSIP	Miegs	50-500 mcg	10 mg	2 ml	Tikai kalkulators	Aprēķināt
5-Amino-1MQ	Metabolais	2,5-10 mg	10 mg	2 ml	Tikai kalkulators	Aprēķināt
Pinealon	Pētniecības peptīds	-	10 mg	2 ml	Tikai kalkulators	Aprēķināt
Survodutide	GLP-1/glikagons	-	10 mg	2 ml	Tikai kalkulators	Aprēķināt
Kisspeptin-10	KISS1R / GPR54	-	10 mg	2 ml	Tikai kalkulators	Aprēķināt
HGH 191AA	Augšanas hormons	1-5 mg	10 mg	1 ml	Tikai kalkulators	Aprēķināt
NAD+	Ilmūžība / kofaktors	100-500 mg	1000 mg	10 ml	Tikai kalkulators	Aprēķināt

Vērtības ir orientējošas pētniecības kontekstā un neaizstāj profesionālu padomu.

Kāpēc svarīga precīza peptīdu dozēšana

Koncentrācijas un injekcijas tilpuma pareiza aprēķināšana šķiet vienkārša, taču tā ir visbiežākais kļūdu avots. Pat 10 % kļūda rekonstituēšanas laikā nozīmē, ka saņemat pārāk maz aktīvās vielas vai netīšām pārdozējat.

Liofilizēti peptīdi tiek piegādāti miligramos un izšķīdināti bakteriostatiskajā ūdenī (BAC ūdens). Peptīda un ūdens attiecība nosaka koncentrāciju, un no tās izriet, cik vienības uzvelkat insulīna šļircē. Insulīna šļirces ir graduētas vienībās, nevis miligramos. Kalkulators veic šo pārrēķinu, tostarp ticamības pārbaudi pret bīstamāko kļūdu: mg un mcg sajaukšanu.

BUJ

Biežāk uzdotie jautājumi

Kāda ir atšķirība starp mcg un mg?

Miligrami (mg) ir vienība, kādā pārdod liofilizētus peptīdus, piemēram, „5 mg BPC-157”. Mikrogrami (mcg) raksturo atsevišķu devu, piemēram, „250 mcg uz injekciju”. 1 mg = 1000 mcg. Kalkulators pārrēķina automātiski un brīdina, ja ievadītais lielums izskatās pēc sajaukšanas.

Ko nozīmē „U-100” uz manas insulīna šļirces?

U-100 nozīmē, ka šļirce ir kalibrēta 100 vienībām mililitrā. 100 SV = 1 ml, tātad 10 SV = 0,10 ml neatkarīgi no tā, kas ir šļircē. SV aprēķins balstās tieši uz šo attiecību.

Kāpēc kalkulators dažkārt rāda ļoti mazus tilpumus?

Ja peptīda ir daudz un ūdens maz, šķīdums kļūst ļoti koncentrēts, tāpēc tilpums uz devu ir niecīgs un grūti nolasāms. Izmantojiet sajaukšanas palīgu: tas atrod ūdens tilpumu, kas dod tīru, viegli nolasāmu atzīmi.

Cik ilgi saglabājas rekonstituēts peptīds?

Ledusskapī 2-8 °C temperatūrā parasti 21-30 dienas. Marķējiet flakonu ar rekonstituēšanas datumu. Duļķains šķīdums vai daļiņas nav pieņemami.

Kā kalkulators darbojas ar maisījumiem, piemēram, Glow Stack?

Maisījumi satur vairākas aktīvās vielas vienā flakonā. Vienkārši izvēlieties maisījumu kā savu peptīdu: kalkulators papildus parāda, cik daudz katras sastāvdaļas ir jūsu injekcijā. Vairāku atsevišķu flakonu kombinācijām izmantojiet Stack Builder.

Vai kalkulators katru reizi jāaizpilda no jauna?

Nē. Jūsu pēdējie iestatījumi tiek saglabāti lokāli pārlūkprogrammā un atjaunoti nākamajā apmeklējumā. Aprēķinus varat arī atsaukt no vēstures, saglabāt kā protokolu vai kopīgot ar saiti.

Saistītie peptīdi

AOD-9604Tauku vielmaiņa IpamorelinGHRP TesamorelinGHRH analogs

Visi kalkulatori

Izvēlieties peptīdu

Izvēlieties peptīdu, lai atvērtu tam veltīto kalkulatora lapu ar jau aizpildītām vērtībām.

HGH Fragment 176-191 kalkulators

Galvenie fakti

What Is HGH Fragment 176-191?

Mechanisms of Action

Dosage Calculation

Standard Dosing Parameters

Example Calculation: 10 mg Vial with 2 mL BAC Water

Injection Site and Timing Selection

Reconstitution

Step-by-Step Reconstitution Protocol

Storage and Shelf Life

Side Effects and Safety Profile

Commonly Reported Observations

Less Common or Theoretical Concerns

Contraindications

Combinations and Stacks

HGH Fragment 176-191 and AOD-9604

HGH Fragment 176-191 and GH Secretagogues

HGH Fragment 176-191 and Tesamorelin

Frequently Asked Questions

How does HGH Fragment 176-191 differ from real growth hormone?

Does the fragment raise IGF-1 levels?

Is the fragment a GH secretagogue?

Why is the fragment often used in a fasted state?

Does injecting into a specific body area cause local fat loss?

How do HGH Fragment 176-191 and AOD-9604 differ?

Why is the fragment often dosed several times per day?

Where can I buy HGH Fragment 176-191?

Kā rekonstituēt peptīdu

Sagatavojiet BAC ūdeni

Uzvelciet ūdeni

Pievienojiet lēni

Ļaujiet izšķīst

Uzvelciet devu

Devas un flakonu izmēri pa peptīdiem

Kāpēc svarīga precīza peptīdu dozēšana

Biežāk uzdotie jautājumi

Saistītie peptīdi

Izvēlieties peptīdu

VIP

Retatrutide

Cagrilintide

Semaglutide

Tirzepatide

GHK-Cu

AHK-Cu

BPC-157

TB-500

CJC-1295 (bez DAC)

Ipamorelin

AOD-9604

PT-141

MOTS-c

Selank

SS-31

Glow Stack

Klow Stack

Melanotan II

Melanotan I

Sermorelin

Tesamorelin

Thymosin Alpha-1

Epithalon

KPV

Semax

N-Acetyl Semax

Hexarelin

GHRP-6

GHRP-2

DSIP

5-Amino-1MQ

Pinealon

Survodutide

Kisspeptin-10

HGH 191AA

NAD+

HGH Fragment 176-191 kalkulators

Galvenie fakti

What Is HGH Fragment 176-191?

Mechanisms of Action